Zastosowanie immunoterapii u dzieci z neuroblastomą wysokiego ryzyka

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Authors and Affiliations

Elwira Szychot, Jarosław Peregud-Pogorzelski, Paweł Wawryków, Andrzej Brodkiewicz

Keywords

Related Articles

Antyoksydacyjne i przeciwdrobnoustrojowe właściwości bioaktywnych fitozwiązków żurawiny

W racjonalnym żywieniu człowieka podkreśla się rolę owoców i warzyw, będących źródłem tzw. bioaktywnych fitozwiązków. Wśród owoców szczególną uwagę zwraca żurawina ze względu na wiele udokumentowanych właściwości prozdro...

Autophagy, new perspectives in anticancer therapy

Autophagy, the process of degradation of unwanted or damaged cell elements, is extremely important for a variety of human diseases, especially cancers. This process influences various stages of initiation and progression...

Structure, regulation and functions of particulate guanylyl cyclase type A

Guanylyl cyclase type A (GC-A) belongs to the particulate guanylyl cyclases (pGC), which, like the soluble guanylyl cyclases (sGC), catalyze the synthesis of a common secondary messenger, namely cyclic GMP (cGMP), involv...

The role of the class A scavenger receptors, SR-A and MARCO, in the immune system. Part 2. Contribution to recognition and phagocytosis of pathogens as well as induction of immune response

Recognition of pathogens by innate immune cells is mediated by pattern recognition receptors (PRR), which include the class A scavenger receptors (SR), SR-A/CD204 and MARCO. It seems that in addition to activating inn...

Selenium in Graves' disease

The aim of this study was to present the current state of knowledge of the role of selenium in Graves’ disease. Recently, in the pathogenesis and course of this autoimmune disease, more attention has been paid to the rel...

Download PDF file
  • EP ID EP220858
  • DOI -
  • Views 156
  • Downloads 0

How To Cite

Elwira Szychot, Jarosław Peregud-Pogorzelski, Paweł Wawryków, Andrzej Brodkiewicz (2016). Zastosowanie immunoterapii u dzieci z neuroblastomą wysokiego ryzyka. Advances in Hygiene and Experimental Medicine, 70(), 1001-1004. https://europub.co.uk/articles/-A-220858